{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T11:13:54Z","timestamp":1775819634311,"version":"3.50.1"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T00:00:00Z","timestamp":1774915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T00:00:00Z","timestamp":1775779200000},"content-version":"vor","delay-in-days":10,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Johann Wolfgang Goethe-Universit\u00e4t, Frankfurt am Main"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rosai Dorfman disease is a rare histiocytosis, which is characterized by accumulation of histiocytes in lymph nodes, but also in extranodal locations. Histologically, one of the key features of Rosai Dorfman disease is emperipolesis. Treatment options involve surgical resection, radiation, chemotherapy, corticosteroids, and immunotherapy. Rosai Dorfman disease treatment depends on disease location and symptomatology. Patients with mild nodal or cutaneous involvement usually have a self-limited course and require observation only. The exact pathogenesis of Rosai Dorfman disease is still being evaluated, but mutations of the Kirsten rat sarcoma virus gene are found in up to a third of the patients and are linked to multifocal disease. Recent publications and case reports have shown that treatment with the mitogen-activated protein kinase kinase inhibitor Cobimetinib is a possible option in Rosai Dorfman disease patients with Kirsten rat sarcoma virus gene mutation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation<\/jats:title>\n                    <jats:p>In this case report, we are presenting and discussing the case of a 47-year-old Caucasian female patient with multifocal Rosai Dorfman disease and simultaneous endometrioid ovarian cancer, who underwent median laparotomy for tumor debulking of the endometrioid ovarian cancer and in which a Kirsten rat sarcoma virus gene mutation was detected and a treatment with Cobimetinib was initiated, leading to sustained remission.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>While there are case reports on patients with Rosai Dorfman disease with a simultaneous cancer diagnosis, and while some authors describe Rosai Dorfman disease as a possible neoplastic process itself, it remains unclear if there is a causal association between Rosai Dorfman disease and cancer.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s13256-025-05772-4","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T19:25:56Z","timestamp":1774985156000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multifocal Rosai Dorfman disease and simultaneous endometrioid ovarian cancer: a case report"],"prefix":"10.1186","volume":"20","author":[{"given":"Nele","family":"Graf","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Halbsguth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sven","family":"Becker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morva","family":"Tahmasbi Rad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,3,31]]},"reference":[{"key":"5772_CR1","doi-asserted-by":"publisher","first-page":"1329","DOI":"10.1002\/pbc.25017","volume":"61","author":"SR Vaiselbuh","year":"2014","unstructured":"Vaiselbuh SR, Bryceson YT, Allen CE, Whitlock JA, Abla O. Updates on histiocytic disorders. Pediatr Blood Cancer. 2014;61:1329\u201335. https:\/\/doi.org\/10.1002\/pbc.25017.","journal-title":"Pediatr Blood Cancer"},{"issue":"1","key":"5772_CR2","first-page":"63","volume":"87","author":"J Rosai","year":"1969","unstructured":"Rosai J, Dorfman RF. Sinus histiocytosis with massive lymphadenopathy. A newly recognized benign clinicopathological entity. Arch Pathol. 1969;87(1):63\u201370.","journal-title":"Arch Pathol"},{"key":"5772_CR3","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1038\/s41591-021-01304-x","volume":"27","author":"C Bigenwald","year":"2021","unstructured":"Bigenwald C, Chakraborty R, Chen ST. BRAFV600E-induced senescence in hematopoietic progenitors drives Langerhans cell histiocytosis pathophysiology. Nat Med. 2021;27:851\u201361.","journal-title":"Nat Med"},{"issue":"1","key":"5772_CR4","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1038\/s41572-021-00307-9","volume":"7","author":"KL McClain","year":"2021","unstructured":"McClain KL, Bigenwald C, Collin M, Haroche J, Marsh RA, Merad M, et\u00a0al. Histiocytic disorders. Nat Rev Dis Primers. 2021;7(1):73. https:\/\/doi.org\/10.1038\/s41572-021-00307-9.","journal-title":"Nat Rev Dis Primers"},{"key":"5772_CR5","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1182\/blood-2018-03-839753","volume":"131","author":"O Abla","year":"2018","unstructured":"Abla O, Jacobsen E, Picarsic J, Krenova Z, Jaffe R, Emile JF, et\u00a0al. Consensus recommendations for the diagnosis and clinical management of Rosai\u2013Dorfman-Destombes disease. Blood. 2018;131:2877\u201390. https:\/\/doi.org\/10.1182\/blood-2018-03-839753.","journal-title":"Blood"},{"issue":"21","key":"5772_CR6","doi-asserted-by":"publisher","DOI":"10.3390\/cancers14215271","volume":"14","author":"I ElbazYounes","year":"2022","unstructured":"ElbazYounes I, Sokol L, Zhang L. Rosai\u2013Dorfman disease between proliferation and neoplasia. Cancers. 2022;14(21): 5271. https:\/\/doi.org\/10.3390\/cancers14215271.","journal-title":"Cancers"},{"issue":"5","key":"5772_CR7","doi-asserted-by":"publisher","first-page":"388","DOI":"10.32074\/1591-951X-548","volume":"113","author":"C Doglioni","year":"2021","unstructured":"Doglioni C. Rosai\u2013Dorfman disease. A legacy of Professor Rosai that is still not exploited completely. Pathologica. 2021;113(5):388\u201395. https:\/\/doi.org\/10.32074\/1591-951X-548.","journal-title":"Pathologica"},{"issue":"12","key":"5772_CR8","doi-asserted-by":"publisher","first-page":"ZM01","DOI":"10.7860\/JCDR\/2014\/10361.5299","volume":"8","author":"V Rastogi","year":"2014","unstructured":"Rastogi V, Sharma R, Misra SR, Yadav L, Sharma V. Emperipolesis\u2014A review. J Clin Diagn Res. 2014;8(12):ZM01\u20132. https:\/\/doi.org\/10.7860\/JCDR\/2014\/10361.5299.","journal-title":"J Clin Diagn Res"},{"key":"5772_CR9","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1016\/j.joms.2015.09.017","volume":"74","author":"TH Al-Khateeb","year":"2016","unstructured":"Al-Khateeb TH. Cutaneous Rosai\u2013Dorfman disease of the face: a comprehensive literature review and case report. J Oral Maxillofac Surg. 2016;74:528\u201340.","journal-title":"J Oral Maxillofac Surg"},{"key":"5772_CR10","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1179\/016164109X12608733393836","volume":"32","author":"AO Adeleye","year":"2010","unstructured":"Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S. Diagnosis and management of Rosai\u2013Dorfman disease involving the central nervous system. Neurol Res. 2010;32:572\u20138.","journal-title":"Neurol Res"},{"key":"5772_CR11","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMc1713676","volume":"377","author":"E Jacobsen","year":"2017","unstructured":"Jacobsen E, Shanmugam V, Jagannathan J. Rosai\u2013Dorfman disease with activating KRAS mutation\u2014Response to cobimetinib. N Engl J Med. 2017;377:2398\u20139.","journal-title":"N Engl J Med"},{"key":"5772_CR12","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1016\/j.clim.2016.12.006","volume":"175","author":"RJ Ragotte","year":"2017","unstructured":"Ragotte RJ, Dhanrajani A, Pleydell-Pearce J, Del Bel KL, Tarailo-Graovac M, van Karnebeek C, et\u00a0al. The importance of considering monogenic causes of autoimmunity: a somatic mutation in KRAS causing pediatric Rosai\u2013Dorfman syndrome and systemic lupus erythematosus. Clin Immunol. 2017;175:143\u20136.","journal-title":"Clin Immunol"},{"key":"5772_CR13","doi-asserted-by":"publisher","first-page":"1348","DOI":"10.5858\/2001-125-1348-RDDOTP","volume":"125","author":"R Juskevicius","year":"2001","unstructured":"Juskevicius R, Finley JL. Rosai\u2013Dorfman disease of the parotid gland: cytologic and histopathologic findings with immunohistochemical correlation. Arch Pathol Lab Med. 2001;125:1348\u201350.","journal-title":"Arch Pathol Lab Med"},{"issue":"10","key":"5772_CR14","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1038\/modpathol.2017.55","volume":"30","author":"S Garces","year":"2017","unstructured":"Garces S, Medeiros LJ, Patel KP, Li S, Pina-Oviedo S, Li J, et\u00a0al. Mutually exclusive recurrent KRAS and MAP2K1 mutations in Rosai\u2013Dorfman disease. Mod Pathol. 2017;30(10):1367\u201374. https:\/\/doi.org\/10.1038\/modpathol.2017.55.","journal-title":"Mod Pathol"},{"issue":"11","key":"5772_CR15","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1136\/jclinpath-2020-206733","volume":"73","author":"C Bruce-Brand","year":"2020","unstructured":"Bruce-Brand C, Schneider JW, Schubert P. Rosai\u2013Dorfman disease: an overview. J Clin Pathol. 2020;73(11):697\u2013705. https:\/\/doi.org\/10.1136\/jclinpath-2020-206733.","journal-title":"J Clin Pathol"},{"issue":"10","key":"5772_CR16","doi-asserted-by":"publisher","DOI":"10.1136\/bcr-2024-262184","volume":"17","author":"E Proskuriakova","year":"2024","unstructured":"Proskuriakova E, Shunyakov L, Hoffmann MS. Rare presentation and unconventional treatment of Rosai\u2013Dorfman disease. BMJ Case Rep. 2024;17(10): e262184. https:\/\/doi.org\/10.1136\/bcr-2024-262184.","journal-title":"BMJ Case Rep"},{"issue":"1","key":"5772_CR17","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12895-020-00115-w","volume":"20","author":"A Bielach-Bazyluk","year":"2020","unstructured":"Bielach-Bazyluk A, Serwin AB, Pilaszewicz-Puza A, Flisiak I. Cutaneous Rosai\u2013Dorfman disease in a patient with late syphilis and cervical cancer\u2014Case report and a review of literature. BMC Dermatol. 2020;20(1):19. https:\/\/doi.org\/10.1186\/s12895-020-00115-w.","journal-title":"BMC Dermatol"},{"issue":"9","key":"5772_CR18","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1177\/00031348221091963","volume":"88","author":"MA Merrell","year":"2022","unstructured":"Merrell MA, Grenn EE, Orr III. Rosai\u2013Dorfman disease of the chest wall following mastectomy for breast cancer. Am Surg. 2022;88(9):2221\u20132. https:\/\/doi.org\/10.1177\/00031348221091963.","journal-title":"Am Surg"},{"issue":"4","key":"5772_CR19","doi-asserted-by":"publisher","first-page":"432","DOI":"10.1097\/PGP.0b013e3182a03d23","volume":"33","author":"LY Pan","year":"2014","unstructured":"Pan LY, Offman SL, Warnke RA, Longacre TA. Uterine Rosai\u2013Dorfman disease (sinus histiocytosis with massive lymphadenopathy). Int J Gynecol Pathol. 2014;33(4):432\u20136. https:\/\/doi.org\/10.1097\/PGP.0b013e3182a03d23.","journal-title":"Int J Gynecol Pathol"},{"issue":"5","key":"5772_CR20","doi-asserted-by":"publisher","first-page":"1000","DOI":"10.1111\/j.1447-0756.2009.01054.x","volume":"35","author":"M Yamaguchi","year":"2009","unstructured":"Yamaguchi M, Yahata T, Fujita K, Sakurada J, Hasegawa G, Umezu H, et\u00a0al. Extranodal Rosai\u2013Dorfman disease involving bilateral ovaries in a patient with a ventriculoperitoneal shunt. J Obstet Gynaecol Res. 2009;35(5):1000\u20133. https:\/\/doi.org\/10.1111\/j.1447-0756.2009.01054.x.","journal-title":"J Obstet Gynaecol Res"},{"issue":"4","key":"5772_CR21","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1038\/modpathol.3880071","volume":"13","author":"D Lu","year":"2000","unstructured":"Lu D, Estalilla OC, Manning JT Jr, Medeiros LJ. Sinus histiocytosis with massive lymphadenopathy and malignant lymphoma involving the same lymph node: a report of four cases and review of the literature. Mod Pathol. 2000;13(4):414\u20139. https:\/\/doi.org\/10.1038\/modpathol.3880071.","journal-title":"Mod Pathol"},{"issue":"7","key":"5772_CR22","doi-asserted-by":"publisher","first-page":"742","DOI":"10.1016\/j.pathol.2016.07.015","volume":"48","author":"J Hassani","year":"2016","unstructured":"Hassani J, Porubsky C, Berman C, Zager J, Messina J, Henderson-Jackson E. Intraperitoneal Rosai\u2013Dorfman disease associated with clear cell sarcoma: first case report. Pathology. 2016;48(7):742\u20134. https:\/\/doi.org\/10.1016\/j.pathol.2016.07.015.","journal-title":"Pathology"},{"issue":"3","key":"5772_CR23","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1002\/pbc.21606","volume":"51","author":"S Ambati","year":"2008","unstructured":"Ambati S, Chamyan G, Restrepo R, Escalon E, Fort J, Pefkarou A, et\u00a0al. Rosai\u2013Dorfman disease following bone marrow transplantation for pre-B cell acute lymphoblastic leukemia. Pediatr Blood Cancer. 2008;51(3):433\u20135. https:\/\/doi.org\/10.1002\/pbc.21606.","journal-title":"Pediatr Blood Cancer"},{"issue":"4","key":"5772_CR24","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.prp.2007.01.008","volume":"203","author":"E Long","year":"2007","unstructured":"Long E, Lassalle S, Cheikh-Rouhou R, Hofman V, Lacour JP, Hofman P. Intestinal occlusion caused by Rosai\u2013Dorfman disease mimicking colonic diverticulitis. Pathol Res Pract. 2007;203(4):233\u20137. https:\/\/doi.org\/10.1016\/j.prp.2007.01.008.","journal-title":"Pathol Res Pract"},{"issue":"2","key":"5772_CR25","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.path.2019.01.009","volume":"12","author":"O Fadare","year":"2019","unstructured":"Fadare O, Parkash V. Pathology of endometrioid and clear cell carcinoma of the ovary. Surg Pathol Clin. 2019;12(2):529\u201364. https:\/\/doi.org\/10.1016\/j.path.2019.01.009.","journal-title":"Surg Pathol Clin"},{"issue":"2","key":"5772_CR26","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.yexmp.2013.08.004","volume":"95","author":"M Rechsteiner","year":"2013","unstructured":"Rechsteiner M, Zimmermann AK, Wild PJ, Caduff R, von Teichman A, Fink D, et\u00a0al. TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type. Exp Mol Pathol. 2013;95(2):235\u201341. https:\/\/doi.org\/10.1016\/j.yexmp.2013.08.004.","journal-title":"Exp Mol Pathol"},{"issue":"16","key":"5772_CR27","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa1008433","volume":"363","author":"KC Wiegand","year":"2010","unstructured":"Wiegand KC, Shah SP, Al-Agha OM, Zhao Y, Tse K, Zeng T, et\u00a0al. ARID1A mutations in endometriosis-associated ovarian carcinomas. N Engl J Med. 2010;363(16):1532\u201343. https:\/\/doi.org\/10.1056\/NEJMoa1008433.","journal-title":"N Engl J Med"},{"issue":"3","key":"5772_CR28","doi-asserted-by":"publisher","first-page":"626","DOI":"10.1210\/en.2018-00794","volume":"160","author":"SE Bulun","year":"2019","unstructured":"Bulun SE, Wan Y, Matei D. Epithelial mutations in endometriosis: link to ovarian cancer. Endocrinology. 2019;160(3):626\u201338. https:\/\/doi.org\/10.1210\/en.2018-00794.","journal-title":"Endocrinology"},{"issue":"3","key":"5772_CR29","doi-asserted-by":"publisher","first-page":"667","DOI":"10.1111\/bjh.17258","volume":"192","author":"NR Wilson","year":"2021","unstructured":"Wilson NR, Fang H, Loghavi S, Wang W, Tang G, Haltom RO, et\u00a0al. Treating Rosai\u2013Dorfman disease and RAS-associated autoimmune leucoproliferative disorder with malignant transformation. Br J Haematol. 2021;192(3):667\u201371. https:\/\/doi.org\/10.1111\/bjh.17258.","journal-title":"Br J Haematol"},{"issue":"2","key":"5772_CR30","doi-asserted-by":"publisher","DOI":"10.12890\/2022_003076","volume":"9","author":"K L\u00f3pez-Aldabe","year":"2022","unstructured":"L\u00f3pez-Aldabe K, Escrihuela-Vidal F, Tuells-Morales M, Llobera-Ris C, Bauer-Alonso A, Cortes-Romera M, et\u00a0al. Multiple drug regimen-refractory Rosai\u2013Dorfman-Destombes disease mimicking relapsing polychondritis successfully treated with cobimetinib. Eur J Case Rep Intern Med. 2022;9(2): 003076. https:\/\/doi.org\/10.12890\/2022_003076.","journal-title":"Eur J Case Rep Intern Med"},{"key":"5772_CR31","unstructured":"FDA approves oral MEK inhibitor cobimetinib for histiocytic neoplasms, research led by Memorial Sloan Kettering Cancer Center. News release. Memorial Sloan Kettering Cancer Center, November 1, 2022. Accessed 2 Nov 2022."},{"issue":"7749","key":"5772_CR32","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1038\/s41586-019-1012-y","volume":"567","author":"EL Diamond","year":"2019","unstructured":"Diamond EL, Durham BH, Ulaner GA, Drill E, Buthorn J, Ki M, et\u00a0al. Efficacy of MEK inhibition in patients with histiocytic neoplasms. Nature. 2019;567(7749):521\u20134. https:\/\/doi.org\/10.1038\/s41586-019-1012-y.","journal-title":"Nature"}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13256-025-05772-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-025-05772-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,10]],"date-time":"2026-04-10T10:19:08Z","timestamp":1775816348000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s13256-025-05772-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3,31]]},"references-count":32,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["5772"],"URL":"https:\/\/doi.org\/10.1186\/s13256-025-05772-4","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,3,31]]},"assertion":[{"value":"11 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 March 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable (case report). The patient gave informed consent to the publication of this data, the institutional consent form for research participant publication approval by SpringerNature was used to obtain consent.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Written informed consent was obtained from the patient for publication of this case report and any accompanying images. A copy of the written consent is available for review by the Editor-in-Chief of this journal.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"179"}}